192
Views
21
CrossRef citations to date
0
Altmetric
Review

The genetics of hereditary spastic paraplegia and implications for drug therapy

, MD
Pages 1433-1439 | Published online: 30 Jul 2007

Bibliography

  • HARDING AE: Classification of the hereditary ataxias and paraplegias. Lancet (1983) 1(8334):1151-1155.
  • DURR A, CAMUZAT A, COLIN E et al.: Atlastin 1 mutations are frequent in young-onset autosomal dominant spastic paraplegia 1. Arch. Neurol. (2004) 61(12):1867-1872.
  • FILLA A, DE MICHELE G, MARCONI R et al.: Prevalence of hereditary ataxias and spastic paraplegias in Molise, a region of Italy. J. Neurol. (1992) 239(6):351-353.
  • POLO JM, CALLEJA J, COMBARROS O, BERCIANO J: Hereditary ataxias and paraplegias in Cantabria, Spain. An epidemiological and clinical study. Brain (1991) 114(Part 2):855-866.
  • EYMARD-PIERRE E, LESCA G, DOLLET S et al.: Infantile-onset ascending hereditary spastic paralysis is associated with mutations in the alsin gene. Am. J. Hum. Genet. (2002) 71(3):518-527.
  • HADANO S, HAND CK, OSUGA H et al.: A gene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. (2001) 29(2):166-173.
  • ZUCHNER S, VANCE JM: Emerging pathways for hereditary axonopathies. J. Mol. Med. (2005) 83(12):935-943.
  • HANEMANN CO, LUDOLPH AC: Hereditary motor neuropathies and motor neuron diseases: which is which. Amyotroph. Lateral Scler. Other Motor Neuron Disord. (2002) 3(4):186-189.
  • IROBI J, DE JONGHE P, TIMMERMAN V: Molecular genetics of distal hereditary motor neuropathies. Hum. Mol. Genet. (2004) 13(Spec No 2):R195-R202.
  • CORK LC, GRIFFIN JW, ADAMS RJ, PRICE DL: Animal model of human disease: motor neuron disease: spinal muscular atrophy and amyotrophic lateral sclerosis. Am. J. Pathol. (1980) 100(2):599-602.
  • FINK JK: Advances in the hereditary spastic paraplegias. Exp. Neurol. (2003) 184(Suppl. 1):S106-S110.
  • SODERBLOM C, BLACKSTONE C: Traffic accidents: molecular genetic insights into the pathogenesis of the hereditary spastic paraplegias. Pharmacol. Ther. (2006) 109(1-2):42-56.
  • REID E, KLOOS M, ASHLEY-KOCH A et al.: A kinesin heavy chain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am. J. Hum. Genet. (2002) 71(5):1189-1194.
  • HANSEN JJ, DURR A, COURNU-REBEIX I et al.: Hereditary spastic paraplegia SPG13 is associated with a mutation in the gene encoding the mitochondrial chaperonin Hsp60. Am. J. Hum. Genet. (2002) 70(5):1328-1332.
  • BEETZ C, NYGREN AO, SCHICKEL J et al.: High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology (2006) 67(11):1926-1930.
  • ZUCHNER S, WANG G, TRAN-VIET KN et al.: Mutations in the novel mitochondrial protein REEP1 cause hereditary spastic paraplegia type 31. Am. J. Hum. Genet. (2006) 79(2):365-369.
  • BARTEL DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 116(2):281-297.
  • CROSS HE, MCKUSICK VA: The Troyer syndrome. A recessive form of spastic paraplegia with distal muscle wasting. Arch. Neurol. (1967) 16(5):473-485.
  • PATEL H, CROSS H, PROUKAKIS C et al.: SPG20 is mutated in Troyer syndrome, an hereditary spastic paraplegia. Nat. Genet. (2002) 31(4):347-348.
  • CROSS HE, MCKUSICK VA: The mast syndrome. A recessively inherited form of presenile dementia with motor disturbances. Arch. Neurol. (1967) 16(1):1-13.
  • SIMPSON MA, CROSS H, PROUKAKIS C et al.: Maspardin is mutated in mast syndrome, a complicated form of hereditary spastic paraplegia associated with dementia. Am. J. Hum. Genet. (2003) 73(5):1147-1156.
  • STEVANIN G, SANTORELLI FM, AZZEDINE H et al.: Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat. Genet. (2007) 39(3):366-372.
  • BLUMEN SC, BEVAN S, ABU-MOUCH S et al.: A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24 – q32. Ann. Neurol. (2003) 54(6):796-803.
  • ORLACCHIO A, KAWARAI T, GAUDIELLO F, GEORGE-HYSLOP PH, FLORIS R, BERNARDI G: New locus for hereditary spastic paraplegia maps to chromosome 1p31.1 – 1p21.1. Ann. Neurol. (2005) 58(3):423-429.
  • REID E: Science in motion: common molecular pathological themes emerge in the hereditary spastic paraplegias. J. Med. Genet. (2003) 40(2):81-86.
  • ERRICO A, BALLABIO A, RUGARLI EI: Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum. Mol. Genet. (2002) 11(2):153-163.
  • FONKNECHTEN N, MAVEL D, BYRNE P et al.: Spectrum of SPG4 mutations in autosomal dominant spastic paraplegia. Hum. Mol. Genet. (2000) 9(4):637-644.
  • SVENSON IK, ASHLEY-KOCH AE, PERICAK-VANCE MA, MARCHUK DA: A second leaky splice-site mutation in the spastin gene. Am. J. Hum. Genet. (2001) 69(6):1407-1409.
  • MCDERMOTT CJ, GRIERSON AJ, WOOD JD et al.: Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann. Neurol. (2003) 54(6):748-759.
  • WOOD JD, LANDERS JA, BINGLEY M et al.: The microtubule-severing protein spastin is essential for axon outgrowth in the zebrafish embryo. Hum. Mol. Genet. (2006) 15(18):2763-2771.
  • TROTTA N, ORSO G, ROSSETTO MG, DAGA A, BROADIE K: The hereditary spastic paraplegia gene, spastin, regulates microtubule stability to modulate synaptic structure and function. Curr. Biol. (2004) 14(13):1135-1147.
  • ORSO G, MARTINUZZI A, ROSSETTO MG, SARTORI E, FEANY M, DAGA A: Disease-related phenotypes in a Drosophila model of hereditary spastic paraplegia are ameliorated by treatment with vinblastine. J. Clin. Invest. (2005) 115(11):3026-3034.
  • EVANS K, KELLER C, PAVUR K, GLASGOW K, CONN B, LAURING B: Interaction of two hereditary spastic paraplegia gene products, spastin and atlastin, suggests a common pathway for axonal maintenance. Proc. Natl. Acad. Sci. USA (2006) 103(28):10666-10671.
  • LEE Y, PAIK D, BANG S et al.: Loss of spastic paraplegia gene atlastin induces age-dependent death of dopaminergic neurons in Drosophila. Neurobiol. Aging (2006).
  • MANNAN AU, KRAWEN P, SAUTER SM et al.: ZFYVE27 (SPG33), a novel spastin-binding protein, is mutated in hereditary spastic paraplegia. Am. J. Hum. Genet. (2006) 79(2):351-357.
  • HASPEL J, GRUMET M: The L1CAM extracellular region: a multi-domain protein with modular and cooperative binding modes. Front. Biosci. (2003) 8:s1210-s1225.
  • NISHIMURA K, YOSHIHARA F, TOJIMA T et al.: L1-dependent neuritogenesis involves ankyrin B that mediates L1CAM coupling with retrograde actin flow. J. Cell Biol. (2003) 163(5):1077-1088.
  • DE ANGELIS E, WATKINS A, SCHAFER M, BRUMMENDORF T, KENWRICK S: Disease-associated mutations in L1CAM interfere with ligand interactions and cell-surface expression. Hum. Mol. Genet. (2002) 11(1):1-12.
  • DAHME M, BARTSCH U, MARTINI R, ANLIKER B, SCHACHNER M, MANTEI N: Disruption of the mouse L1 gene leads to malformations of the nervous system. Nat. Genet. (1997) 17(3):346-349.
  • CAMBI F, TARTAGLINO L, LUBLIN F, MCCARREN D: X-linked pure familial spastic paraparesis. Characterization of a large kindred with magnetic resonance imaging studies. Arch. Neurol. (1995) 52(7):665-669.
  • MCLAUGHLIN M, BARRIE JA, KARIM S et al.: Processing of PLP in a model of Pelizaeus-Merzbacher disease/SPG2 due to the rumpshaker mutation. Glia (2006) 53(7):715-722.
  • ATORINO L, SILVESTRI L, KOPPEN M et al.: Loss of m-AAA protease in mitochondria causes complex I deficiency and increased sensitivity to oxidative stress in hereditary spastic paraplegia. J. Cell Biol. (2003) 163(4):777-787.
  • CASARI G, DE FUSCO M, CIARMATORI S et al.: Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell (1998) 93(6):973-983.
  • FERREIRINHA F, QUATTRINI A, PIROZZI M et al.: Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport. J. Clin. Invest. (2004) 113(2):231-242.
  • DE LORENZI E, GIORGETTI S, GROSSI S, MERLINI G, CACCIALANZA G, BELLOTTI V: Pharmaceutical strategies against amyloidosis: old and new drugs in targeting a “protein misfolding disease”. Curr. Med. Chem. (2004) 11(8):1065-1084.
  • ESTRADA LD, SOTO C: Inhibition of protein misfolding and aggregation by small rationally-designed peptides. Curr. Pharm. Des. (2006) 12(20):2557-2567.
  • OHTSUKA K, KAWASHIMA D, GU Y, SAITO K: Inducers and co-inducers of molecular chaperones. Int. J. Hyperthermia (2005) 21(8):703-711.
  • LU J, RASHID F, BYRNE PC: The hereditary spastic paraplegia protein spartin localises to mitochondria. J. Neurochem. (2006) 98(6):1908-1919.
  • SAITO H, KUBOTA M, ROBERTS RW, CHI Q, MATSUNAMI H: RTP family members induce functional expression of mammalian odorant receptors. Cell (2004) 119(5):679-691.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.